Siryus Multiplex Immunoassay Technology

Proprietary microarray technology platform for immunological testing and allergen detection. Enables high-throughput analysis of biological markers in clinical diagnostics.

Point-of-care platform enabling simultaneous quantification of up to 8 biomarkers from 20-50 µl of capillary blood in 15 minutes. CE-IVD and IVDR certified technology designed for OEM integration and personalized medicine applications.

Syndromic molecular diagnostics platform utilizing high-multiplex real-time PCR technology to simultaneously detect multiple pathogens. Integrates automated testing systems with AI-powered assay development and global diagnostic data intelligence for infectious disease detection and surveillance.

A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.

Customized immunoassay and multi-omics diagnostic solutions leveraging microsystems technology and nanoponetechnology for rapid, precise disease detection. Enables development of epigenetic and molecular biomarker tests from concept through manufacturing, reducing turnaround time and complexity compared to conventional laboratory methods.

A CE-IVD certified rapid test platform that enables fully automated quantification of up to 8 (or 16) biomarkers in parallel from capillary blood or other specimens. The system combines accelerated hybridization through novel microfluidics technology with chemiluminescence-based optical detection and automated reagent dispensing via cartridge system. It is designed for point-of-care multiplex testing applications, allowing customers to perform laboratory ELISA tests faster with smaller sample volumes.

Comprehensive diagnostic test platform utilizing microarray technology for detection of multiple disease markers simultaneously. Requires high-precision liquid handling for accurate kit manufacturing.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.

Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.

Advanced multiplex immunohistochemistry detection system enabling simultaneous staining with multiple antibodies on a single slide. Reduces turnaround time and simplifies laboratory procedures.

Complex multiplex bead systems for medical and non-medical diagnostic applications. These solutions enable multiple assays within a single device while maintaining stability, consistency, and simplified manufacturing processes.